Quote from hels02:
How can something that kills cancer cells be 'carcinogenic'? Can you explain that better?
This is remarkable... I can't see why they won't just give it to people who are terminal... there are a lot of dying hospices I thought? If it didn't work, how could it hurt?
Thanks for posting that... if true, does that mean that all these drugs coming down the pipe for cancer (DNDN, CEGE, few others come to mind) are coming out with worthless concoctions with no chance at profit because the problem has already been cheaply solved?
It works on selective cell-lines. Some tumors are less dependent on glycolysis and hence will not be helped by inhibiting the Warburg effect. The carcinogenicity is linear dose dependent.
Dendreon's molecule is a band-aid. It will likely be approved because it's an immunotherapeutic and well tolerated. It's not the answer by a long shot.
